124 related articles for article (PubMed ID: 7949100)
1. Loxoribine induces chronic lymphocytic leukemia B cells to traverse the cell cycle.
Goodman MG; Wormsley SB; Spinosa JC; Piro LD
Blood; 1994 Nov; 84(10):3457-64. PubMed ID: 7949100
[TBL] [Abstract][Full Text] [Related]
2. New perspectives on the approach to chronic lymphocytic leukemia.
Goodman MG; Spinosa JC; Saven A; Piro LD; Wormsley S
Leuk Lymphoma; 1996 Jun; 22(1-2):1-10. PubMed ID: 8724523
[TBL] [Abstract][Full Text] [Related]
3. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
[TBL] [Abstract][Full Text] [Related]
4. Loxoribine affects fludarabine activity on freshly isolated B-chronic lymphocytic leukemia cells.
Tosi P; Zinzani PL; Pellacani A; Ottaviani E; Magagnoli M; Tura S
Leuk Lymphoma; 1997 Jul; 26(3-4):343-8. PubMed ID: 9322897
[TBL] [Abstract][Full Text] [Related]
5. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
6. Hairy cell leukemia, a B-cell neoplasm that is particularly sensitive to the cytotoxic effect of anti-Tac(Fv)-PE38 (LMB-2).
Robbins DH; Margulies I; Stetler-Stevenson M; Kreitman RJ
Clin Cancer Res; 2000 Feb; 6(2):693-700. PubMed ID: 10690555
[TBL] [Abstract][Full Text] [Related]
7. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
[TBL] [Abstract][Full Text] [Related]
8. Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
al-Katib A; Wang CY; McKenzie S; Clarkson BD; Koziner B
Am J Hematol; 1992 Aug; 40(4):264-9. PubMed ID: 1354412
[TBL] [Abstract][Full Text] [Related]
9. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
Aljurf M; Cornbleet PJ; Michel F
Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
11. Identification of monoclonal immunoglobulins and quantitative immunoglobulin abnormalities in hairy cell leukemia and chronic lymphocytic leukemia.
Hansen DA; Robbins BA; Bylund DJ; Piro LD; Saven A; Ellison DJ
Am J Clin Pathol; 1994 Nov; 102(5):580-5. PubMed ID: 7942620
[TBL] [Abstract][Full Text] [Related]
12. Expression of differentiation and activation antigens on peripheral blood mononuclear cells in chronic lymphocytic leukaemia (CLL) and in hairy-cell leukaemia (HCL).
Pálóczi K; Demeter J; Hokland P; Petrányi GG
Eur J Haematol; 1990 Nov; 45(5):285-6. PubMed ID: 2261961
[No Abstract] [Full Text] [Related]
13. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
Sokol L; Agosti SJ
Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
[TBL] [Abstract][Full Text] [Related]
14. Surface phenotype and adhesion activity of B-cell chronic lymphoid leukemias.
Takeuchi H; Katayama I
Leuk Lymphoma; 1993 Jun; 10(3):209-16. PubMed ID: 8220119
[TBL] [Abstract][Full Text] [Related]
15. Leukemic cells in hairy cell leukemia and B cell chronic lymphocytic leukemia release soluble TNF receptors.
Trentin L; Pizzolo G; Zambello R; Agostini C; Morosato L; Sancetta R; Adami F; Vinante F; Chilosi M; Gallati H
Leukemia; 1995 Jun; 9(6):1051-5. PubMed ID: 7596168
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
17. B-cell chronic lymphocytic leukaemia populations respond stochastically to combinations of growth signals in vitro.
McManus AP; Desai ZR; Lavabre-Bertrand T
Leuk Res; 1993 Jun; 17(6):477-81. PubMed ID: 8505846
[TBL] [Abstract][Full Text] [Related]
18. Hybrid form of hairy cell leukemia and chronic lymphocytic leukemia.
Sun T; Susin M; Shevde N; Teichberg S
Hematol Oncol; 1990; 8(5):283-94. PubMed ID: 1979043
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
20. Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: malignant cell phenotypes define distinct disease subsets.
De Rossi G; Zarcone D; Mauro F; Cerruti G; Tenca C; Puccetti A; Mandelli F; Grossi CE
Blood; 1993 May; 81(10):2679-87. PubMed ID: 7683926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
